The Necessity of Monitoring the Consumption of Metabolic and Dietary Infant Formulas
The Director General of Natural, Traditional, Supplementary Products and Infant Formula of the Food and Drug Administration emphasized monitoring the clinical condition of patients and managing the consumption of metabolic and dietary products.
The Director General of Natural, Traditional, Supplementary Products and Infant Formula of the Food and Drug Administration emphasized monitoring the clinical condition of patients and managing the consumption of metabolic and dietary products.
According to a report by IRIB News Agency, Shahram Shoaibi, Director General of Natural, Traditional, Supplementary Products and Infant Formula of the Food and Drug Administration, said: The delivery of metabolic and dietary products is carried out upon presentation of a doctor's prescription and a visit at least once every three months, so that the clinical condition of patients and their consumption quota are regularly monitored.
He added: Receiving metabolic products, in addition to a doctor's prescription and periodic visits, requires registration and identity verification in the Hami system.
The Director General of Natural, Traditional, Supplementary Products and Infant Formula of the Food and Drug Administration emphasized: The technical managers of pharmacies are obliged to comply with the specified requirements, and supervision over the implementation of the directive in the process of registering information in the TTAC system and distributing the products is the responsibility of the food and drug deputies of the universities of medical sciences.
Shoaibi noted: The implementation of this directive is carried out with the aim of monitoring the clinical condition of patients, managing consumption quotas, and organizing the distribution of metabolic and dietary products.
